CLRB

Transfer...

Symbol:

NASDAQ / Sector: Healthcare / Sub-Sector: Biotechnology / Stock Type: Slow Growth
# of Employee: 19 / Fiscal Year End: 2016-12-31 / Stock Type: Small Core
USD / Exchange Rate: 1 at 2016-11-22 / Estimation: $Confidential / / $

Cellectar Biosciences Inc is a biopharmaceutical company. It is engaged in developing compounds for treatment and imaging of cancer. Its portfolio consists of PET imaging agents, optical imaging agents and therapeutic agents.

Competitors | QuarterReport

Competitors List | Key Matrix Details

AMGN | GILD | CELG | NVO | BIIB | SHPG | REGN | ALXN | VRTX | INCY | BMRN | CLCD |

Finance Highlights

Key Ratio Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDate	PeriodType	ROE	FCFMargin	FCFPerShar	EquityPerS	ProfitMarg	Continuous	NetMargin	DebtEquity	CurrentRat
2008-12-25	Annual	311.20%	-13,797.90%	-12,941.8	-4,158.2	100.00%	-13,060.00%	-13,060.00%	-0.792	4.753
2009-12-25	Annual	39.50%	-11,043.40%	-6,521.4	-16,490.2	100.00%	-23,125.70%	-23,125.70%	-0.751	1.912
2010-12-25	Annual	-646.80%	-23,412.40%	-1,894.7	292.9	100.00%	6,286.10%	6,286.10%	0.962	.364

Key Ratio Trend

ReportDate	PeriodType	ROE	FCFMargin	FCFPerShar	EquityPerS	ProfitMarg	Continuous	NetMargin	DebtEquity	CurrentRat
Average	Annual	-1,737.47%	-112.00%	49.61%	-296.57%	0.00%	-77.07%	-77.07%	5.18%	-80.96%
2009-12-25	Annual	-87.31%	19.96%	49.61%	-296.57%	0.00%	-77.07%	-77.07%	5.18%	-59.77%
2010-12-25	Annual	-1,737.47%	-112.00%	70.95%	101.78%	0.00%	127.18%	127.18%	228.10%	-80.96%

Income Statement Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDate	PeriodType	Revenue	Cost	InterestEx	Continuous	NetIncome	DilutedSha	ProfitMarg	Continuous	NetMargin
2008-12-25	Annual	125,968.0	0.0	0.0	-16,451,406.0	-16,451,406.0	1,343	100.00%	-13,060.00%	-13,060.00%
2009-12-25	Annual	96,314.0	0.0	0.0	-22,273,306.0	-22,273,306.0	1,631	100.00%	-23,125.70%	-23,125.70%
2010-12-25	Annual	33,334.0	0.0	0.0	2,095,392.0	2,095,392.0	4,119	100.00%	6,286.10%	6,286.10%

Income Statement Trend

ReportDate	PeriodType	Revenue	Cost	InterestEx	Continuous	NetIncome	DilutedSha	ProfitMarg	Continuous	NetMargin
Average	Annual	-65.39%	0.00%	0.00%	-35.39%	-35.39%	21.44%	0.00%	-77.07%	-77.07%
2009-12-25	Annual	-23.54%	0.00%	0.00%	-35.39%	-35.39%	21.44%	0.00%	-77.07%	-77.07%
2010-12-25	Annual	-65.39%	0.00%	0.00%	109.41%	109.41%	152.54%	0.00%	127.18%	127.18%

Balance Sheet Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDate	PeriodType	Equity	TotalAsset	TotalLiabi	CurrentAss	CurrentLia	NonCurrent	DebtEquity	CurrentRat
2008-12-25	Annual	-5,584,501.0	1,466,038.0	7,050,539.0	1,392,237.0	6,617,206.0	433,333.0	-0.792	4.753
2009-12-25	Annual	-26,895,538.0	8,931,899.0	35,827,437.0	8,872,452.0	16,967,818.0	18,859,619.0	-0.751	1.912
2010-12-25	Annual	1,206,609.0	2,460,582.0	1,253,973.0	2,436,477.0	887,306.0	366,667.0	0.962	.364

Balance Sheet Trend

ReportDate	PeriodType	Equity	TotalAsset	TotalLiabi	CurrentAss	CurrentLia	NonCurrent	DebtEquity	CurrentRat
Average	Annual	-381.61%	-72.45%	-96.50%	-72.54%	-94.77%	-98.06%	5.18%	-80.96%
2009-12-25	Annual	-381.61%	509.25%	408.15%	537.28%	156.42%	4,252.22%	5.18%	-59.77%
2010-12-25	Annual	104.49%	-72.45%	-96.50%	-72.54%	-94.77%	-98.06%	228.10%	-80.96%

Cash Flow Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDate	PeriodType	OperatingC	CAPEX	FreeCashFl	Investment	FinancialF
2008-12-25	Annual	-17,331,895.0	-49,003.0	-17,380,898.0	1,135,699.0	7,717,130.0
2009-12-25	Annual	-10,618,338.0	-18k	-10,636,338.0	-18k	18,143,415.0
2010-12-25	Annual	-7,804,283.0	0.0	-7,804,283.0	0.0	1,407,705.0

Cash Flow Trend

ReportDate	PeriodType	OperatingC	CAPEX	FreeCashFl	Investment	FinancialF
Average	Annual	26.50%	63.27%	26.63%	-101.58%	-92.24%
2009-12-25	Annual	38.74%	63.27%	38.80%	-101.58%	135.11%
2010-12-25	Annual	26.50%	100.00%	26.63%	100.00%	-92.24%

Finance Detail

Income Statement Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##IncomeSheetDetail}

Balance Sheet Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##BalanceSheetDetail}

Cash Flow Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##CashFlowDetail}

Note